These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

774 related items for PubMed ID: 28898541

  • 1. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
    Busard CI, Cohen AD, Wolf P, Gkalpakiotis S, Cazzaniga S, Stern RS, Hutten BA, Feldhamer I, Quehenberger F, Lichem R, Kojanova M, Adenubiova E, Addis A, Naldi L, Spuls PI.
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):245-253. PubMed ID: 28898541
    [Abstract] [Full Text] [Related]

  • 2. Biologic drug survival in Israeli psoriasis patients.
    Shalom G, Cohen AD, Ziv M, Eran CB, Feldhamer I, Freud T, Berman E, Oren S, Hodak E, Pavlovsky L.
    J Am Acad Dermatol; 2017 Apr; 76(4):662-669.e1. PubMed ID: 28038888
    [Abstract] [Full Text] [Related]

  • 3. Drug survival of conventional systemic and biologic therapies for moderate-to-severe psoriasis in clinical practice in Spain: prospective results from the SAHARA study.
    Puig L, Carrascosa JM, Daudén E, Sulleiro S, Guisado C.
    J Dermatolog Treat; 2020 Jun; 31(4):344-351. PubMed ID: 30888880
    [Abstract] [Full Text] [Related]

  • 4. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
    Garber C, Plotnikova N, Au SC, Sorensen EP, Gottlieb A.
    J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
    [Abstract] [Full Text] [Related]

  • 5. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW, Bagel J, Van Voorhees AS, Robertson AD, Yamauchi PS.
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [Abstract] [Full Text] [Related]

  • 6. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
    Garber C, Creighton-Smith M, Sorensen EP, Dumont N, Gottlieb AB.
    J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
    [Abstract] [Full Text] [Related]

  • 7. Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists.
    Mahé E, Beauchet A, Hadj-Rabia S, Mazereeuw-Hautier J, Mallet S, Phan A, Severino-Freire M, Boralevi F, Aubert H, Barthélémy H, Girard C, Martin L, Piram M, Barbarot S, Balguerie X, Zitouni J, Phan C, Di Lernia V, Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie (SFD), Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), and Società Italiana di Dermatologia Pediatrica (S.I.Der.P.).
    Dermatol Ther; 2022 Nov; 35(11):e15828. PubMed ID: 36107157
    [Abstract] [Full Text] [Related]

  • 8. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
    Kojanova M, Fialova J, Cetkovska P, Gkalpakiotis S, Jircikova J, Dolezal T, Arenberger P, BIOREP study group.
    Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
    Bissonnette R, Kerdel F, Naldi L, Papp K, Galindo C, Langholff W, Tang KL, Szapary P, Fakharzadeh S, Srivastava B, Goyal K, Gottlieb AB.
    J Drugs Dermatol; 2017 Oct 01; 16(10):1002-1013. PubMed ID: 29036254
    [Abstract] [Full Text] [Related]

  • 10. Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users.
    Ighani A, Yu AM, Sandhu VK, Barankin B, Manolson MF.
    J Cutan Med Surg; 2019 Oct 01; 23(2):148-156. PubMed ID: 30801221
    [Abstract] [Full Text] [Related]

  • 11. The 'switcher' patient profile in psoriasis treatment: from traditional to biological and from biological to traditional systemic drugs.
    Tabolli S, Giannantoni P, Paradisi A, Abeni D.
    Br J Dermatol; 2015 Jul 01; 173(1):256-8. PubMed ID: 25422080
    [No Abstract] [Full Text] [Related]

  • 12. Combining traditional agents and biologics for the treatment of psoriasis.
    Cather JC, Menter A.
    Semin Cutan Med Surg; 2005 Mar 01; 24(1):37-45. PubMed ID: 15900797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Psoriasis in the mature patient: Therapeutic approach in the era of biologics.
    Kostović K, Žužul K, Čeović R, Bukvić Mokos Z.
    Clin Dermatol; 2018 Mar 01; 36(2):222-230. PubMed ID: 29566926
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
    Ross C, Marshman G, Grillo M, Stanford T.
    Australas J Dermatol; 2016 May 01; 57(2):137-40. PubMed ID: 25754697
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
    Takeshita J, Wang S, Shin DB, Callis Duffin K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Robertson AD, Linn KA, Shinohara RT, Troxel AB, Van Voorhees AS, Gelfand JM.
    J Am Acad Dermatol; 2014 Dec 01; 71(6):1167-75. PubMed ID: 25260564
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.